Pelvic girdle pain (PGP) during pregnancy is a major source of stress for mothers. This review summarizes studies on the effectiveness of functional stability exercises (FSEs) in preventing PGP during pregnancy. FSE is a rising area of study in maternal health, focusing on core muscle groups and addressing the biomechanical changes during pregnancy. Although data shows that FSE may relieve PGP and improve the quality of life in pregnant women, the research landscape is defined by limitations and differences in intervention parameters among studies, resulting in contradictory conclusions. As a result, the efficacy of FSE in pregnant women with PGP remains inconclusive. This review can help comprise the existing research on FSE alleviating PGP in pregnancy to provide full knowledge on the topic, analyze long-term effects, and develop practice guidelines. While FSE shows promise, treating the multidimensional nature of PGP in pregnancy requires a comprehensive approach to therapy that incorporates several therapeutic modalities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10719549 | PMC |
| http://dx.doi.org/10.7759/cureus.48769 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Validity and reliability of the Polish version of the Pregnancy Mobility Index (PMI-PL).
Front Public Health
October 2024
Department of Human Biological Development, Faculty of Sport Sciences, Poznan University of Physical Education, Poznań, Poland.
Article Synopsis
- Mobility issues due to low back pain and pelvic girdle pain affect pregnant women, prompting the need for the Pregnancy Mobility Index (PMI) to assess their mobility.
- A Polish version of the PMI was developed through a thorough transcultural adaptation process, involving 121 pregnant women and assessing its reliability and validity.
- The adapted PMI for Poland showed high reliability and strong correlations with physical activity levels, making it a useful tool for health professionals to monitor the mobility and encourage safe physical activity for pregnant women.*
Absolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug Disposition.
Drug Metab Dispos
October 2024
Systems Pharmacology, Manchester Pharmacy School, University of Manchester, United Kingdom.
Article Synopsis
- The study focuses on the role of the placenta in drug transport and nutrient transfer, identifying key transporters in human placenta and various cell lines.
- Researchers found significant expression levels of transporters like P-gp, BCRP, MRP2, MRP4, and MRP6, with some notable differences between tissue and cell line models.
- The findings suggest that proteomic analysis combined with a physiologically-based pharmacokinetic (PBPK) model can accurately predict fetal drug exposure and offers a standardized approach for future studies on maternal and fetal drug interactions.
Modelling the maternal-fetal interface: An in vitro approach to investigate nutrient and drug transport across the human placenta.
J Cell Mol Med
October 2024
Institute of Biochemistry and Molecular Medicine, Faculty of Medicine, University of Bern, Bern, Switzerland.
The placenta plays a critical role in maternal-fetal nutrient transport and fetal protection against drugs. Creating physiological in vitro models to study these processes is crucial, but technically challenging. This study introduces an efficient cell model that mimics the human placental barrier using co-cultures of primary trophoblasts and primary human umbilical vein endothelial cells (HUVEC) on a Transwell-based system.
View Article and Find Full Text PDFHuman trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport.
Toxicol Appl Pharmacol
November 2024
Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China. Electronic address:
ATP-binding cassette (ABC) transporters, the important transmembrane efflux transporters, play an irreplaceable role in the placenta barrier. The disposition and drug-drug interaction of clinical drugs are also closely related to the functions of ABC transporters. The trophoblast is a unique feature of the placenta, which is crucial for normal placentation and maintenance during pregnancy.
View Article and Find Full Text PDFP-glycoprotein expression is decreased in placenta accreta and placenta previa disorders.
Minerva Obstet Gynecol
September 2024
Department of Biomedical, Experimental and Clinical Sciences "Mario Serio, " University of Florence, Florence, Italy.
Background: P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) are multidrug resistance (MDR) transporters that function as placental gatekeepers, lowering the fetal levels of diverse xenobiotics and toxins that may be circulating in the maternal blood throughout pregnancy. Placenta accreta spectrum (PAS) and the placenta previa (PP) disorders are obstetric pathologies encompassed by an abnormal invasion of chorionic villous tissue in the uterine wall or at the endocervical os, respectively. Given the fact that MDR transporters are involved in placentation and are highly responsive to inflammation, we hypothesized that immunostaining of P-gp and BCRP would be altered in PAS and in PP specimens.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!